• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Holdings
© 2025 Longbridge|Disclaimer

Schedules & Filings

Schedules
Filings
Sep26
Distribution Plan(EST)

Cash dividend 0.2363 USD

Sep22
Distribution Plan(EST)

Cash dividend 0.2363 USD

Distribution Plan(EST)

Cash dividend 0.2363 USD

View More

Event Tracking

Dec18
Eli Lilly Announces Positive Results for orforglipron Weight Maintenance Trial
11:47
Eli Lilly's Olfiglutide Meets Clinical Trial Endpoints
11:47
Eli Lilly Submits New Drug Application for Obesity Treatment to FDA
11:45
Ransom Advisory Ltd increased holdings in Eli Lilly in Q3
11:34
Eli Lilly reportedly to cut prices of Mounjaro and Zepbound in Canada by over 20% starting December 29
09:41
Eli Lilly's blockbuster diabetes drug Tirzepatide included in China's National Reimbursement Drug List (NRDL)
09:30